Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorthalidone vs Hydrochlorothiazide on Endothelial Function in Hypertension
NCT01822860Phase 4Withdrawn
- Sponsor
- Creighton University
- Start
- Mar 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorthalidone in hypertension (HTN), sponsored by Creighton University. Planned start Mar 2013; status: withdrawn.
02
Drugs
chlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01822860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822860.